A new study – using lab mice genetically modified with a human gene to shed light on a potential link between arsenic exposure and diabetes – revealed that while the male mice exposed to arsenic in drinking water developed diabetes, the female mice did not.
A new study, which brought together Cornell researchers, Cambodian fishers and Cambodian researchers, had study participants take photos that researchers then use to facilitate interviews and group discussions during which the subjects share their life experiences and perspectives.
A new method could be used by biologists to estimate the prevalence of disease in free-ranging wildlife and help determine how many samples are needed to detect a disease.
When Dead & Company came to Cornell in May for a benefit concert commemorating the Grateful Dead’s famed “Cornell ’77” show, it drew thousands to Barton Hall. The March announcement of the show was the most-viewed Chronicle story of 2023.
Restricting the number of ingredients in the diet lessens signs of disease in dogs with persistent gastrointestinal diseases, a study by researchers in the Department of Clinical Sciences in the Cornell College of Veterinary Medicine has found.
Cornell researchers have released a new open-source platform, Cascade, that can run artificial intelligence models in a way that slashes expenses and energy costs while dramatically improving performance.
Researchers created a new technique to treat Type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while avoiding the immunosuppression that typically stymies management of the disease.
Researchers have identified an important pathway that reveals why some mammals, like humans, dogs and cats, regularly develop mammary cancer while others, such as horses, pigs and cows, rarely do.
New research has shown that ultrasmall Cornell Prime Dots, or C’Dots, which are among the nanocarriers for therapeutics once thought to be viable only by injection, have the potential to be administered orally.
